Jeannie T. Lee active positions
| Companies | Position | Start | End |
|---|---|---|---|
| GSK PLC | Director/Board Member | 2024-03-03 | - |
| The Genetics Society of America | Director/Board Member | - | - |
Career history of Jeannie T. Lee
Former positions of Jeannie T. Lee
| Companies | Position | Start | End |
|---|---|---|---|
| TRANSLATE BIO, INC. | Founder | 2010-12-31 | - |
| FULCRUM THERAPEUTICS, INC. | Founder | 2015-08-17 | - |
Training of Jeannie T. Lee
| Harvard University | Undergraduate Degree |
| Perelman School of Medicine | Doctorate Degree |
Statistics
International
| United States | 6 |
| United Kingdom | 2 |
Operational
| Director/Board Member | 2 |
| Founder | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| FULCRUM THERAPEUTICS, INC. | Health Technology |
| GSK PLC | Health Technology |
| Private companies | 2 |
|---|---|
| The Genetics Society of America | |
Translate Bio, Inc.
 Translate Bio, Inc. BiotechnologyHealth Technology Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA. | Health Technology |
- Stock Market
- Insiders
- Jeannie T. Lee
- Experience
